Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

Journal of Clinical Investigation

Volumn 105, Issue 11, 2000, Pages 1641-1649

  Pyo, Robert ^a,b   Lee, Jason K ^a   Shipley, J Michael ^a   Curci, John A ^a   Mao, Dongli ^a   Ziporin, Scott J ^a   Ennis, Terri L ^a   Shapiro, Steven D ^a   Senior, Robert M ^a   Thompson, Robert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELMHURST HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; ELASTOLYSIS; EXTRACELLULAR MATRIX; GENE DISRUPTION; GENE TARGETING; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TISSUE INJURY;

EID: 0034090148     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8931     Document Type: Article

References (39)

1. Cole, C.W., et al. 1994. Proceedings of the workshop on the control of abdominal aortic aneurysm. Chronic Dis. Can. 15(Suppl.):S1-S64.
2. Thompson, R.W. 1996. Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem. Curr. Opin. Cardiol. 11:504-518.
3. Dobrin, P.B., and Mrkvicka, R. 1994. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardrovasc Surg. 2:484-488.
4. Shah, P.K. 1997. Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation. 96:2115-2117.
5. Parks, W.C., Pierce, R.A., Lee, K.A., and Mecham, R.P. 1993. Elastin. Advances in Molecular Cell Biology. 6:133-182.
6. Freestone, T., et al. 1995. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 15:1145-1151.
7. Davis, V., et al. 1998. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 18:1625-1633.
8. Thompson, R.W., et al. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96:318-326.
9. Curci, J.A., Liao, S., Huffman, M.D., Shapiro, S.D., and Thompson, R.W. 1998. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J. Clin. Invest. 102:1900-1910.
10. McMillan, W.D., et al. 1997. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation. 96:2228-2232.
11. McMillan, W.D., and Pearce, W.H. 1999. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J. Vasc. Surg. 29:122-127.
12. Dobrin, P.B. 1999. Animal models of aneurysms. Ann. Vasc. Surg. 13:641-648.
13. Anidjar, S., et al. 1990. Elastase induced experimental aneurysms in rats. Circulation. 82:973-981.
14. Anidjar, S., Dobrin, P.B., Eichorst, M., Graham, G.P., and Chejfec, G. 1992. Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysm. J Vasc. Surg. 16:139-147.
15. Halpern, V.J., et al. 1994. The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response J. Vasc. Surg. 20:51-60.
16. Petrinec, D., et al. 1996. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J. Vasc. Surg. 23:336-346.
17. Curci, J.A., Petrinec, D., Liao, S.X., Golub, L.M., and Thompson, R.W. 1998. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J. Vasc. Surg. 28:1082-1093.
18. Bigatel, U.A., et al. 1999. The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J. Vasc. Surg. 29:130-138.
19. Moore, G., et al. 1999. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamare-based matrix metalloproteinase inhibitor (RS 132908). J. Vasc. Surg. 29:522-532.
20. Vu, T.H., et al. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:411-422.
21. Shipley, J.M., Wesselschmidt, R.L., Kobayashi, D.K., Ley, T.J., and Shapiro, S.D. 1996. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc. Natl. Acad. Sci. USA. 93:3942-3946.
22. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., and Shapiro, S.D. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277:2002-2004.
23. Senior, R.M., Griffin, G.L., and Mecham, R.P. 1980. Chemotactic activity of elastin-derived peptides. J. Clin. Invest. 66:859-862.
24. Corcoran, M.L., Kibbey M.C., Kleinman, H.K., and Wahl, L.M. 1995. Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases. J. Biol. Chem. 270:10365-10368.
25. Golub, L.M., et al. 1998. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv. Dent. Res. 12:12-26.
26. Curci, J.A., et al. 2000. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J. Vasc. Surg. 31:325-342.
27. Senior, R.M., et al. 1991. Human 92-and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266:7870-7875.
28. Carmeliet, P., et al. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat. Genet. 17:439-444.
29. Allaire, E., et al. 1998. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation. 98:249-255.
30. Thompson, R.W., and Parks, W.C. 1996. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann. NY Acad. Sci. 800:157-174.
31. Shapiro, S.D., et al. 1995. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J. Biol. Chem. 270:6351-6356.
32. Mazzieri, R., et al. 1997. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J. 16:2319-2332.
33. Ferry, G., et al. 1997. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett. 402:111-115.
34. Sukhova, G.K., Shi, G.P., Simon, D.I., Chapman, H.A., and Libby, P. 1998. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102:576-583.
35. Goldberg, G.I., Strongin, A., Collier, I.E., Genrich, L.T., and Marmer, B.L. 1992. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267:4583-4591.
36. Betsuyaku, T., Shipley, J.M., Liu, Z., and Senior, R.M. 1999. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am. J. Respir. Cell Mol. Biol. 20:1303-1309.
37. Liu, Z., et al. 1998. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188:475-482.
38. Alcorn, H.G., Wolfson, S.K., Jr., Sutton-Tyrrell, K., Kuller, L.H., and O'Leary, D. 1996 Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 16:963-970.
39. Thompson, R.W., and Baxter, B.T. 1999. MMP inhibition in abdominal aorric aneurysms: rationale for a prospective randomized clinical trial. Ann. NY Acad. Sci. 878:159-178.